ChilversMcCrea and TBSGB

ChilversMcCrea Healthcare is pleased to announce the formation of a new company, ChilversMcCreaTBSGB ltd, formed through an alliance between ChilversMcCrea Healthcare and TBSGB Ltd. The new company will harness the expertise of the individual companies to provide a range of telemedicine services.

ChilversMcCrea Healthcare, one of the UK’s leading independent providers of urgent care and primary care services to the NHS, has an unrivalled reputation in delivering high quality healthcare; TBSGB ltd, a subsidiary of Europe’s main telemedicine provider with over 20 years experience, has designed Home-Based Telemonitoring Services for CHF and COPD in order to improve quality of care and contain costs to Health Systems by reducing hospital admissions.   ChilversMcCreaTBSGB ltd will enhance the capabilities of both businesses in the treatment of CHF and COPD and other conditions in the UK. It represents a tremendous opportunity to deliver life-changing improvements to patients by embracing a proven model to effectively monitor and treat chronic diseases. ChilversMcCrea Healthcare’s and TBSGB’s combined expertise will deliver a range of innovative tools and services for the NHS and the private sector.  William Moffit, UK Operations Manager for TBSGB commented that Several trials and experiences have demonstrated the cost-effectiveness of Telehealth for treating CHF and COPD. Large-scale randomised clinical trials in Europe determined that Telemonitoring services for heart failure patients can reduce hospitalisations and improve patient well being while reducing the overall cost of care.” 

The new company will leverage the advantages that technology is bringing to primary care in the UK. The combination of medical expertise with state of the art technology differentiates the company from other suppliers of technology solutions and will provide a complete package to complement and enhance current healthcare provision.

 Commenting on the announcement, Dr Sarah Chilvers, Chief Executive of ChilversMcCrea Healthcare, said, "I am delighted to announce the formation of ChilversMcCreaTBSGB Ltd. By working together we are in a position to become the leading independent sector provider of telemedicine services The new company will support Strategic Health Authorities and Primary Care Trusts in monitoring the health of patients with CHF, COPD and other conditions, and provide appropriate interventions to meet their needs, providing patients with an improved, and convenient approach to managing their health and well-being." Professor Nick Bosanquet who joined the Board of TBSGB in early 2006 to develop new services commented: “The NHS faces a powerful series of changes which are going to mean much greater economic pressure on all providers; the formation of this new company provides a very effective model of care whilst addressing the requirements of both healthcare providers and patients alike”.  

For more information please visit the ChilversMcCrea website at http://www.chilversmccrea.co.uk or telephone Antony Dyson on 0161 277 7693

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in


Just published

Young doctor

BMA poll could see 'demeaning' junior doctor title ditched

The BMA could drop the term 'junior doctor' in favour of 'resident doctor' to better...

Houses of parliament

Tory peer calls PA fears 'Luddism' and claims most GP visits 'incredibly straightforward'

Most GP appointments are 'incredibly straightforward' and fears over a wider role...

UK money

NHS pension contribution overhaul to go ahead from April

Changes to NHS pension contribution rates, which will see the top earners required...

BMA sign

BMA warns £800m lost from GP contract since 2019 as last-ditch talks continue

BMA negotiators remain in talks over an improved GP contract offer for 2024/25 just...

GP consultation

GPs still under pressure to prescribe black triangle drug inclisiran

GPs are continuing to face pressure to prescribe the black triangle drug inclisiran...

BMA chair Professor Phil Banfield

Lords urged to block legislation for GMC to regulate PAs

The BMA has urged peers to block legislation that would make the GMC responsible...